399 related articles for article (PubMed ID: 12243834)
41. Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate.
Li C; Ke S; Wu QP; Tansey W; Hunter N; Buchmiller LM; Milas L; Charnsangavej C; Wallace S
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1119-26. PubMed ID: 11072171
[TBL] [Abstract][Full Text] [Related]
42. Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7).
Pradier O; Rave-Fränk M; Schmidberger H; Bömecke M; Lehmann J; Meden H; Hess CF
J Cancer Res Clin Oncol; 1999; 125(1):20-7. PubMed ID: 10037273
[TBL] [Abstract][Full Text] [Related]
43. The in vitro radiosensitization of human glioblastoma with pentoxifylline.
Sperduto PW; Song CW; Levitt SH
Am J Clin Oncol; 1993 Oct; 16(5):407-11. PubMed ID: 8213623
[TBL] [Abstract][Full Text] [Related]
44. Cordycepin increases radiosensitivity in cervical cancer cells by overriding or prolonging radiation-induced G2/M arrest.
Seong da B; Hong S; Muthusami S; Kim WD; Yu JR; Park WY
Eur J Pharmacol; 2016 Jan; 771():77-83. PubMed ID: 26688569
[TBL] [Abstract][Full Text] [Related]
45. Radiobiologic effect of intermittent radiation exposure in murine tumors.
Sugie C; Shibamoto Y; Ito M; Ogino H; Miyamoto A; Fukaya N; Niimi H; Hashizume T
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):619-24. PubMed ID: 16414375
[TBL] [Abstract][Full Text] [Related]
46. Clinical and biological studies of estramustine phosphate as a novel radiation sensitizer.
Kim JH; Khil MS; Kim SH; Ryu S; Gabel M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):555-7. PubMed ID: 8005815
[TBL] [Abstract][Full Text] [Related]
47. Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53.
Bache M; Pigorsch S; Dunst J; Würl P; Meye A; Bartel F; Schmidt H; Rath FW; Taubert H
Int J Cancer; 2001 Apr; 96(2):110-7. PubMed ID: 11291094
[TBL] [Abstract][Full Text] [Related]
48. Influence of pentoxifylline, A-802710, propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage.
Bohm L; Theron T; Binder A
Biochim Biophys Acta; 2000 Dec; 1499(1-2):1-10. PubMed ID: 11118634
[TBL] [Abstract][Full Text] [Related]
49. Radiosensitization and inhibition of deoxyribonucleic acid repair in rat glioma cells by long-term treatment with 12-O-tetradecanoylphorbol 13-acetate.
Zhang W; Hara A; Sakai N; Andoh T; Yamada H; Nozawa Y
Neurosurgery; 1993 Mar; 32(3):432-7; discussion 437. PubMed ID: 8455768
[TBL] [Abstract][Full Text] [Related]
50. In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell line.
Schiano MA; Sevin BU; Perras J; Ramos R; Wolloch EH; Averette HE
Gynecol Oncol; 1991 Oct; 43(1):37-45. PubMed ID: 1959786
[TBL] [Abstract][Full Text] [Related]
51. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.
Russell KJ; Wiens LW; Demers GW; Galloway DA; Plon SE; Groudine M
Cancer Res; 1995 Apr; 55(8):1639-42. PubMed ID: 7712467
[TBL] [Abstract][Full Text] [Related]
52. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines.
Erlich E; McCall AR; Potkul RK; Walter S; Vaughan A
Gynecol Oncol; 1996 Feb; 60(2):251-4. PubMed ID: 8631547
[TBL] [Abstract][Full Text] [Related]
53. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
[TBL] [Abstract][Full Text] [Related]
54. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Wang Y; Dong L; Li J; Luo M; Shang B
Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
[TBL] [Abstract][Full Text] [Related]
55. G2 checkpoint kinase inhibitors exert their radiosensitizing effects prior to the G2/M transition.
Sturgeon CM; Roberge M
Cell Cycle; 2007 Mar; 6(5):572-5. PubMed ID: 17351346
[TBL] [Abstract][Full Text] [Related]
56. Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer.
Edelstein MP; Wolfe LA; Duch DS
Semin Oncol; 1996 Apr; 23(2 Suppl 5):41-7. PubMed ID: 8610236
[TBL] [Abstract][Full Text] [Related]
57. Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity.
Fernet M; Mégnin-Chanet F; Hall J; Favaudon V
DNA Repair (Amst); 2010 Jan; 9(1):48-57. PubMed ID: 19926348
[TBL] [Abstract][Full Text] [Related]
58. PLK1-inhibition can cause radiosensitization or radioresistance dependent on the treatment schedule.
Lund-Andersen C; Patzke S; Nähse-Kumpf V; Syljuåsen RG
Radiother Oncol; 2014 Feb; 110(2):355-61. PubMed ID: 24502970
[TBL] [Abstract][Full Text] [Related]
59. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
[TBL] [Abstract][Full Text] [Related]
60. 1-Methylxanthine enhances the radiosensitivity of tumor cells.
Youn H; Hee Kook Y; Oh ET; Jeong SY; Kim C; Kyung Choi E; Uk Lim B; Park HJ
Int J Radiat Biol; 2009 Feb; 85(2):167-74. PubMed ID: 19280470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
